Trial
NCT04774250
Noise-Induced Hearing Loss-Acute Exposure Treatment (UA)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Washington University School of Medicine
Collaborators
United States Department of Defense; University of Texas; Gateway Biotechnology, Inc.
Condition
Hearing Loss, Noise-Induced
Intervention
Zonisamide 100Mg Cap
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-13